TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33080746

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard rehabilitation program only (non‐NMES group)
Number of subjects: 37
Study: 34412103

Group type: EXPERIMENTAL
Intervention: Aflibercept monotherapy
Number of subjects: 48
Study: 33123739

Group type: EXPERIMENTAL
Intervention: PPT+20%
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PPT+30%
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PPT+40%
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PPT+50%
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PPT+20%, PPT+30%, PPT+40%, PPT+50%
Number of subjects: 22
Study: 33369500

Group type: EXPERIMENTAL
Intervention: Statistical matching technique
Number of subjects: 0
Study: 34773438

Group type: EXPERIMENTAL
Intervention: Group B (microscope-based training)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group A (no additional training)
Number of subjects: 60
Study: 34781822

Group type: EXPERIMENTAL
Intervention: Informative video about cervical cancer
Number of subjects: 63

Group type: COMPARATOR
Intervention: Video on healthy habits (active control)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No intervention (passive control)
Number of subjects: 63

Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 63
Study: 34135953

Group type: EXPERIMENTAL
Intervention: Novel firefly algorithm with deep learning for test data generation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional firefly algorithm
Number of subjects: 0
Study: 32270637

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with opioid drugs (Oxycodone hydrochloride prolonged-release tablet)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxycodone hydrochloride prolonged-release tablet (Control group)
Number of subjects: 60
Study: 34862101

Group type: EXPERIMENTAL
Intervention: Patient-initiated follow-up (PIFU)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine scheduled follow-up
Number of subjects: 34
Study: 33933181

Group type: EXPERIMENTAL
Intervention: MMM intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: HE control
Number of subjects: 241
Study: 35195725

Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Overall ERAS
Number of subjects: 87
Study: 33547453

Group type: EXPERIMENTAL
Intervention: Exposure to online misinformation about COVID-19 vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Factual information about COVID-19 vaccines
Number of subjects: 0
Study: 35638086

Group type: EXPERIMENTAL
Intervention: ilixadencel/sunitinib (ILIXA/SUN)
Number of subjects: 88

Group type: COMPARATOR
Intervention: sunitinib alone (SUN)
Number of subjects: 88
Study: 32520594

Group type: COMPARATOR
Intervention: Novolog
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fiasp
Number of subjects: 19
Study: 34812114

Group type: EXPERIMENTAL
Intervention: 8-h urethral catheter removal
Number of subjects: 300

Group type: COMPARATOR
Intervention: 24-h urethral catheter removal
Number of subjects: 300
Study: 35351381

Group type: EXPERIMENTAL
Intervention: Midazolam (0.5 mg/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Tablet computer
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study: 33605075

Group type: EXPERIMENTAL
Intervention: Acid-etched enamel (EA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acid-etched dentin (DA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laser-conditioned enamel (EL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laser-conditioned dentin (DL)
Number of subjects: 40
Study: 32652432

Group type: EXPERIMENTAL
Intervention: Magnetic resonance enterography and colonography (MREC) with water enema and intravenous spasmolytics
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Water enema and spasmolytics
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Spasmolytics
Number of subjects: 217

Group type: COMPARATOR
Intervention: Gastric content, age, gender, and body mass
Number of subjects: 217
Study: 34991040

Group type: EXPERIMENTAL
Intervention: Self-video group (n=23)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No video control group
Number of subjects: 60
Study: 33222190

Group type: EXPERIMENTAL
Intervention: HBV RNA response (either >2 log HBV RNA decline or >1 log decline resulting in an undetectable value at on-treatment week 24)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: HBV RNA response
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: HBV RNA response with >1 log HBsAg decline
Number of subjects: 279
Study: 33002009

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 65487

Group type: COMPARATOR
Intervention: Non-acupuncture (control)
Number of subjects: 65487
Study: 36397216

Group type: EXPERIMENTAL
Intervention: Huayu Tongluo moxibustion combined with intradermal needling (6 times a week for 4 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Western medication (paroxetine hydrochloride tablets, 20 mg once daily for 4 weeks, max 40 mg/d)
Number of subjects: 50
Study: 36067489

Group type: EXPERIMENTAL
Intervention: Macleaya cordata extract (MCE) at 100 mg/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (commercial diet)
Number of subjects: 6
Study: 33864634

Group type: COMPARATOR
Intervention: Octanoic acid (OA) treatment over a 2-week period
Number of subjects: 16

Group type: COMPARATOR
Intervention: Voice Handicap Index-10 assessment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intrasubject consistency measures
Number of subjects: 16
Study: 32412991

Group type: EXPERIMENTAL
Intervention: Mind-body resilience intervention (Stress Management and Resiliency Training: A Relaxation Response Resiliency Program), 8-week duration.
Number of subjects: 99
Study: 33761856

Group type: EXPERIMENTAL
Intervention: Vestibular stimulation every 2 weeks for 6 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nonstimulation (control group)
Number of subjects: 15
Study: 32151101

Group type: EXPERIMENTAL
Intervention: Bite splint + Platelet-rich plasma injection
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bite splint + Sodium hyaluronate injection
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bite splint + Betamethasone injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bite splint only
Number of subjects: 80
Study: 35835337

Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm2 Baerveldt glaucoma implant)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (0.4 mg/ml for 2 minutes)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Tube shunt
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 242
Study: 32807709

Group type: EXPERIMENTAL
Intervention: Intensive 2-week CRP with booster sessions
Number of subjects: 497

Group type: COMPARATOR
Intervention: Standard 8-week CRP
Number of subjects: 497
Study: 32590828

Group type: EXPERIMENTAL
Intervention: Female authorship
Number of subjects: 2146

Group type: EXPERIMENTAL
Intervention: Female authorship over time
Number of subjects: 2146

Group type: COMPARATOR
Intervention: Characteristics of trials by author gender
Number of subjects: 2146
Study: 35807872

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (CF) 790 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (non-diabetic group)
Number of subjects: 11
Study: 33527729

Group type: EXPERIMENTAL
Intervention: Immediate tissue level (ITL) abutment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Regular healing abutment (Control)
Number of subjects: 64
Study: 33430841

Group type: EXPERIMENTAL
Intervention: KalobaTUSS® syrup
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 34647174

Group type: EXPERIMENTAL
Intervention: Decision Tree (DT) model
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Assisted model (DT model) for radiologists
Number of subjects: 600
Study: 36148830

Group type: EXPERIMENTAL
Intervention: 4L single dose polyethylene glycol (PEG) given in the evening before
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: 4L split-dose PEG
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: 2L split-dose PEG (+ bisacodyl 15 mg)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: 2L single dose PEG (+ bisacodyl 15 mg) in the morning
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Traveling more than an hour
Number of subjects: 641
Study: 32068975

Group type: EXPERIMENTAL
Intervention: 6-month intervention consisting of 2 hours of physical exercise, cognitive training, and classroom study or rest once weekly
Number of subjects: 141

Group type: COMPARATOR
Intervention: OBS-INT group during the observation period
Number of subjects: 141
Study: 34855513

Group type: EXPERIMENTAL
Intervention: Community-level mask distribution and promotion (cloth versus surgical masks)
Number of subjects: 342183

Group type: EXPERIMENTAL
Intervention: Community-level mask distribution and promotion
Number of subjects: 342183

Group type: EXPERIMENTAL
Intervention: Surgical masks distributed with promotion
Number of subjects: 342183
Study: 33185651

Group type: EXPERIMENTAL
Intervention: Higher West African ancestry
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Intensive treatment arm
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Standard treatment arm
Number of subjects: 2466
Study: 35768804

Group type: EXPERIMENTAL
Intervention: High ATIRE risk score
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Nomogram based on ATIRE
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Editing of ATIRE sites
Number of subjects: 228
Study: 35657960

Group type: EXPERIMENTAL
Intervention: Valgus knee brace (Össur Unloader One©) worn for 8 weeks
Number of subjects: 30
Study: 33057976

Group type: EXPERIMENTAL
Intervention: Home visits (2 during pregnancy, 1 postpartum) promoting couple HIV testing and counseling (CHTC) and HIV prevention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 105
Study: 33446133

Group type: EXPERIMENTAL
Intervention: Predictive nomogram based on multivariate logistic regression analysis
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Predictive nomogram
Number of subjects: 207
Study: 34837758

Group type: EXPERIMENTAL
Intervention: Group Acceptance and Commitment Therapy (G‐ACT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 104
Study: 32503649

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 68
Study: 35764983

Group type: EXPERIMENTAL
Intervention: ENGAGE intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 96
Study: 34075778

Group type: EXPERIMENTAL
Intervention: Low-level tragus stimulation (LLTS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham (earlobe stimulation)
Number of subjects: 28
Study: 32712966

Group type: EXPERIMENTAL
Intervention: Hydroxycarbamide (HC)
Number of subjects: 93
Study: 34587830

Group type: EXPERIMENTAL
Intervention: Active RPSS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 0
Study: 35537858

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 20 mg/kg/d, b.i.d. for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 0
Study: 33160781

Group type: EXPERIMENTAL
Intervention: Axillary reverse mapping - selective axillary dissection (ARM-SAD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 100
Study: 32928870

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 993
Study: 35724828

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg/day) and Zinc (15 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-dose treatment with Doxycycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32130851

Group type: EXPERIMENTAL
Intervention: Peer examiner first, then examinee
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group - tested at a station first, then participated as a peer examiner
Number of subjects: 42
Study: 33760280

Group type: EXPERIMENTAL
Intervention: Carrageenan
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 14
Study: 35288227

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation plus adjuvant systemic therapy
Number of subjects: 3083

Group type: COMPARATOR
Intervention: Adjuvant systemic therapy alone
Number of subjects: 3083
Study: 33673616

Group type: EXPERIMENTAL
Intervention: Melatonin rinse solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo rinse solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melatonin in drinking water
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in drinking water
Number of subjects: 0
Study: 36202899

Group type: EXPERIMENTAL
Intervention: Prognostic model based on three necroptosis-related mRNAs (CXCL8, CLEC9A, TAB2)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Tumor immune dysfunction and exclusion scores, M6A-related genes, stem cell correlation, and Tumor mutational burden data
Number of subjects: 291
Study: 33546733

Group type: EXPERIMENTAL
Intervention: AANmDOF robotic training (combination of training in LOPES‐II and conventional gait training, 30 min, 3–5 times a week for 6 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional gait training (30 min, 3–5 times a week for 6 weeks)
Number of subjects: 34
Study: 32182774

Group type: EXPERIMENTAL
Intervention: ADORA2A rs2298383 TT mutated genotype in MCS patients
Number of subjects: 279

Group type: COMPARATOR
Intervention: ADORA2A rs2298383 CT genotype in controls
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: TT MCS patients
Number of subjects: 279
Study: 36078940

Group type: EXPERIMENTAL
Intervention: 4.4 MHz Radiofrequency (RF) therapy
Number of subjects: 118

Group type: COMPARATOR
Intervention: Ultrasound (US) therapy
Number of subjects: 118
Study: 33356519

Group type: EXPERIMENTAL
Intervention: 10-week over-ground robotic-assisted gait training program (n=16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n=18)
Number of subjects: 34
Study: 37079158

Group type: EXPERIMENTAL
Intervention: Iodine intake estimated from 24‐h urinary iodine excretion (UIE)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Iodine intake estimated from 24‐h dietary recall
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Household salt iodine concentration
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Contribution of discretionary salt to daily iodine intake
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Correlation between iodine intake from 24‐h UIE and 24‐h dietary recall
Number of subjects: 103
Study: 34229267

Group type: EXPERIMENTAL
Intervention: Mixed oil intravenous lipid emulsion (MO ILE)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Soybean oil intravenous lipid emulsion (SO ILE)
Number of subjects: 120
Study: 35411669

Group type: EXPERIMENTAL
Intervention: Brensocatib 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brensocatib 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brensocatib 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brensocatib 40 mg (with food)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brensocatib 40 mg (without food)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33258356

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation (SM)
Number of subjects: 55
Study: 32979249

Group type: EXPERIMENTAL
Intervention: Shared room occupancy (group A)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Single room occupancy (group B)
Number of subjects: 666
Study: 33066763

Group type: COMPARATOR
Intervention: Urban slums
Number of subjects: 3671

Group type: COMPARATOR
Intervention: Rural areas
Number of subjects: 3671
Study: 34579199

Group type: EXPERIMENTAL
Intervention: Multifaceted procedure with structured information and three text message reminders sent every two weeks
Number of subjects: 1475

Group type: COMPARATOR
Intervention: Nonstructured information only (control)
Number of subjects: 1475
Study: 33832949

Group type: EXPERIMENTAL
Intervention: Anlotinib (12 mg once daily from day 1 to 14 every 3 weeks)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 91
Study: 34048944

Group type: EXPERIMENTAL
Intervention: Medical scribes deployed in emergency departments and specialty clinics
Number of subjects: 48

Group type: COMPARATOR
Intervention: Comparison group (sites not randomized to intervention)
Number of subjects: 48
Study: 32933755

Group type: EXPERIMENTAL
Intervention: High sensitivity troponin T (hs‐cTnT)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Infarct size (IS) assessed with CMR
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction (LVEF) assessed with CMR
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Pre-discharge TTE-assessed LVEF
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Creatine kinase-MB (CKMB)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: GRACE score
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: TIMI score
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: hs‐cTnT peak value <3,500 ng/L
Number of subjects: 578
Study: 34995805

Group type: EXPERIMENTAL
Intervention: Early surgery (cholecystectomy performed 7 days after MABP)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Delayed surgery (cholecystectomy performed 4 weeks after MABP)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Early surgery
Number of subjects: 198

Group type: COMPARATOR
Intervention: Delayed surgery
Number of subjects: 198
Study: 33243761

Group type: EXPERIMENTAL
Intervention: Transdiagnostic psychological interventions (including signposting, guided self-help, referral to paediatric psychology service)
Number of subjects: 186
Study: 32620213

Group type: EXPERIMENTAL
Intervention: ddMVAC plus durvalumab alone or with tremelimumab
Number of subjects: 120

Group type: COMPARATOR
Intervention: ddMVAC
Number of subjects: 120
Study: 35170786

Group type: EXPERIMENTAL
Intervention: Nurse-led smartphone-based self-management programme (NSSMP) for 6 months
Number of subjects: 114

Group type: COMPARATOR
Intervention: Nurse-led diabetic service (NDS)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Nurse-led smartphone-based self-management programme (NSSMP)
Number of subjects: 114
Study: 34318438

Group type: EXPERIMENTAL
Intervention: Scheduled oral regimen of ibuprofen plus acetaminophen (alternating every 3 hours or concurrent every 6 hours for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HTX-011 (300 mg bupivacaine/9 mg meloxicam)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HTX-011 with ibuprofen/acetaminophen
Number of subjects: 0
Study: 33576284

Group type: EXPERIMENTAL
Intervention: Physical activity prescription (PAP)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (basic information about postoperative PA)
Number of subjects: 121
Study: 33752581

Group type: EXPERIMENTAL
Intervention: Client-clinician dyads with less similar perceptions of the client's subjective social status (SSS)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Clinicians' correct perception of their clients' social status
Number of subjects: 312
Study: 34980096

Group type: EXPERIMENTAL
Intervention: 55% cocoa chocolate (IG1, n = 16)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: White chocolate (IG2, n = 15)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (CG, n = 15)
Number of subjects: 46
Study: 32828187

Group type: EXPERIMENTAL
Intervention: Community engagement and community health worker-led mobile health-supported early detection, initial treatment, and hospital referral of women with hypertension.
Number of subjects: 69330

Group type: COMPARATOR
Intervention: Control group continued local standard of care.
Number of subjects: 69330
Study: 33433847

Group type: EXPERIMENTAL
Intervention: Danhong Injection (40 mL twice a day for a week)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Statins intensive group (atorvastatin 80 mg once, then 40 mg daily for 1 week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (atorvastatin 10–20 mg daily for 1 week)
Number of subjects: 90
Study: 34871590

Group type: EXPERIMENTAL
Intervention: FOODcamp intervention
Number of subjects: 640
Study: 33462619

Group type: EXPERIMENTAL
Intervention: Genetically predicted 1-SD increase of serum IGF-1 levels
Number of subjects: 358072

Group type: EXPERIMENTAL
Intervention: Genetically predicted 1-SD increase of serum IGF-1 levels after adjustment for eBMD
Number of subjects: 358072
Study: 32831169

Group type: EXPERIMENTAL
Intervention: Early Initiation of ART for All (EAAA)
Number of subjects: 3019
Study: 35939965

Group type: EXPERIMENTAL
Intervention: Psychoeducation + advice only (PE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Psychoeducation + simplified motor in‐sensu AAT instruction (AAT0)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Enriched original imaginal retraining technique (AAT+)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 200
Study: 34496940

Group type: EXPERIMENTAL
Intervention: SIMPLS-based model for predicting hospital mortality
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Clinical and comorbidity predictors and blood biochemical markers
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Clustering analysis
Number of subjects: 250
Study: 33726903

Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg or 30 mg once daily)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 220
Study: 33661141

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion (0.05 μg·kg‐1·min‐1) for 30 min before spinal anesthesia
Number of subjects: 177

Group type: COMPARATOR
Intervention: Ephedrine bolus (0.15 mg/kg) before spinal anesthesia
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion
Number of subjects: 177

Group type: COMPARATOR
Intervention: Ephedrine bolus
Number of subjects: 177